RNA quality in fresh frozen prostate tissue from patients operated with radical prostatectomy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 1, 2010, Pages 45-53

  Bertilsson, H ^a,b   Angelsen, A ^a,b   Viset, T ^b   Anderssen, E ^a   Halgunset, J ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cryopreservation; Molecular diagnostic techniques; Oligonucleotide array sequence analysis; Ribonucleases; RNA stability

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; RNA;

ADULT; AGE; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; FROZEN SECTION; GENE EXPRESSION; GLEASON SCORE; HEAT SENSITIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROSCOPY; OPERATION DURATION; ORGAN SIZE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE; PROSTATECTOMY; QUALITATIVE ANALYSIS; RNA ANALYSIS; RNA DEGRADATION; RNA EXTRACTION; RNA STABILITY; STROMA; TEMPERATURE SENSITIVITY; TISSUE SLICE;

AGED; BLOOD LOSS, SURGICAL; CELL LINE, TUMOR; FROZEN SECTIONS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RNA, NEOPLASM; SPECIMEN HANDLING;

EID: 76749114348     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903540815     Document Type: Article

References (33)

1. Damber JE, Aus G. Prostate cancer. Lancet 2008;371: 1710-1721
2. Cooper CS, Campbell C, Jhavar S. Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nature Clin Pract 2007;4:677-687
3. Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 2004;113:913-923
4. Shi L, Perkins RG, Fang H, Tong W. Reproducible and reliable microarray results through quality control: good laboratory profi ciency and appropriate data analysis practices are essential. Curr Opin Biotechnol 2008;19:10-18
5. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005;365:488-492 (Pubitemid 40215731)
6. Morris DS, Tomlins SA, Rhodes DR, Mehra R, Shah RB, Chinnaiyan AM. Integrating biomedical knowledge to model pathways of prostate cancer progression. Cell Cycle 2007;6:1177-1187
7. Medeiros F, Rigl CT, Anderson GG, Becker SH, Halling KC. Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch Pathol Lab Med 2007;131:1805-1816
8. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, Mueller O, Schroeder A, Auffray C. Towards standardization of RNA quality assessment using user-independent classifi ers of microcapillary electrophoresis traces. Nucleic Acids Res 2005;33:e56.
9. Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kornacker K. Chipping away at the chip bias: RNA degradation in microarray analysis. Nature Genetics 2003;35:292-293
10. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 2002;161:1743-1748
11. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 2006; 27:126-139
12. Hawtin P, Hardern I, Wittig R, Mollenhauer J, Poustka A, Salowsky R, Wulff T, Rizzo C, Wilson B. Utility of lab-on-aof chip technology for high-throughput nucleic acid and protein analysis. Electrophoresis 2005;26:3674-3681
13. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;7:3.
14. Copois V, Bibeau F, Bascoul-Mollevi C, Salvetat N, Chalbos P, Bareil C, Candeil L, Fraslon C, Conseiller E, Granci V, Maziere P, Kramar A, Ychou M, Pau B, Martineau P, Molina F, Del Rio M. Impact of RNA degradation on gene expression profi les: assessment of different methods to reliably determine RNA quality. J Biotechnol 2007;127:549-559
15. Lin DW, Coleman IM, Hawley S, Huang CY, Dumpit R, Gifford D, Kezele P, Hung H, Knudsen BS, Kristal AR, Nelson PS. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. J Clin Oncol 2006;24:3763-3770
16. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.
17. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-128
18. Mueller O LS, Schroeder A RNA Integrity Number (RIN) Standardization of RNA Quality Control Tech Rep 5989- 1165EN, Agilent Technologies, Application Note 2004.
19. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression. J Surg Res 2001;99:222-227
20. Schlomm T, Nakel E, Lubke A, Buness A, Chun FK, Steuber T Graefen M, Simon R, Sauter G, Poustka A, Huland H, Erbersdobler A, Sultmann H, Hellwinkel OJ. Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol 2008;53:333-344
21. Guhaniyogi J, Brewer G. Regulation of mRNA stability in mammalian cells. Gene 2001;265:11-23.
22. Koch MO, Smith JA, Jr. Blood loss during radical retropubic prostatectomy: is preoperative autologous blood donation indicated? J Urol 1996;156:1077-1079
23. Moul JW, Sun L, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Donahue T. Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specificantigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national database. Urol Oncol 2003;21:447-455
24. Farnham SB, Webster TM, Herrell SD, Smith JA, Jr. Intraoperative blood loss and transfusion requirements for robotic- assisted radical prostatectomy versus radical retropubic prostatectomy. Urology 2006;67:360-363
25. Best S, Sawers Y, Fu VX, Almassi N, Huang W, Jarrard DF. Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy. Urology 2007;70:328-332
26. Farnsworth WE. Prostate stroma: physiology. Prostate 1999;38:60-72.
27. Strand C, Enell J, Hedenfalk I, Ferno M. RNA quality in frozen breast cancer samples and the Influence on gene expression analysis - a comparison of three evaluation methods using microcapillary electrophoresis traces. BMC Mol Biol 2007;8:38.
28. Bisbal C, Silverman RH. Diverse functions of RNase L and implications in pathology. Biochimie 2007;89:789-798
29. Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L. Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res 2005; 11:8358-8363
30. Sorrentino S, Libonati M. Structure-function relationships in human ribonucleases: main distinctive features of the major RNase types. FEBS Lett 1997;404:1-5.
31. Vincent HA, Deutscher MP. Insights into how RNase R degrades structured RNA: analysis of the nuclease domain. J Mol Biol 2009;387:570-583
32. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantifi cation models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006;28:1601-1613
33. Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, Guenther SM, O'Leary JJ, Sheils O. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fi xed paraffi n-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 2007;7:36.